ClinicalTrials.Veeva

Menu

REASSURE-NIRS Registry (REASSURENIRS)

N

National Cerebral and Cardiovascular Center, Japan

Status

Enrolling

Conditions

Lipid-Rich Atherosclerosis of Coronary Artery

Treatments

Device: near-infrared spectroscopy

Study type

Observational

Funder types

Other

Identifiers

NCT04864171
M30-084-4

Details and patient eligibility

About

RESSURE-NIRS registry is designed to investigate clinical and pathophysiological characteristics of NIRS-derived lipid-rich plaque in patients with coronary artery disease. This is an on-going multi-center prospective registry in Japan.

Full description

NIRS imaging is an invasive intravascular imaging modality to quantitatively visualize lipid-rich atheroma in vivo. While NIRS-derived lipid-rich plaque has been shown to associate with cardiovascular events, there is limited clinical data about the association of this high-risk plaque with risk factors, medication use, prognosis and response of PCI. RESSURE-NIRS registry is an on-going multi-center prospective registry in Japan, which enroll subjects with coronary artery disease who received NIRS imaging to evaluate coronary atherosclerosis. The primary outcome is maximum 4-mm lipid core burden index at coronary lesions measured by NIRS imaging. Secondary major outcomes include entire lipid core burden index, plaque volume, plaque attenuation and echo-lucent area. The anticipated number of study subjects is 2000 cases.

Enrollment

2,000 estimated patients

Sex

All

Ages

20 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients with coronary artery disease clinical indication for coronary angiography and/or percutaneous coronary intervention visualization of coronary lesions with NIRS

Exclusion criteria

poor quality of NIRS images

Trial contacts and locations

2

Loading...

Central trial contact

Kota Murai, MD; Yu Kataoka, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems